On track

Time to get serious on postmarket

June 20, 2019


For years regulators have talked about the importance of continuing monitoring and follow up of approved devices – so called Postmarket Regulation, or Vigilance in Euro-speak.

But frankly, industry focus and regulator resources have always been weighted towards up-front review – premarket evaluation.

That’s all changing. The European MDR includes explicit and comprehensive requirements for postmarket follow up and reporting – and a shiny new database to contain all that information. Australia’s TGA is consulting on a range of new postmarket initiatives and the US FDA recently moved to abandon summary reporting of adverse events, mandating public, case by case reporting of incidents associated with devices such as breast implants.

Join Arthur Brandwood and TJ Thiel to hear why it’s time to get real on Postmarket. And how to manage your devices through the whole lifecycle.



Thursday 20 June

6am Australian Eastern
4am China

Wednesday June 19
9pm London BST

Share this event

Date and Time

June 20, 2019
6:00 am - 7:00 am


Translate »